Oral Vaccination with Different Antigens from Yersinia pestis KIM Delivered by Live Attenuated Salmonella Typhimurium Elicits a Protective Immune Response Against Plague
The use of live recombinant Salmonella attenuated vaccine (RASV) encoding Yersinia proteins is a promising new approach for the vaccination against Yersinia pestis. We have tested the efficacy of 2 proteins, Psn and a portion of LcrV in protecting mice against virulent Yersinia pestis challenge. To remove the immunosuppressive properties of LcrV protein, the lcrV gene, without the TLR2 receptor sequence, was cloned into a β-lactamase secretion vector. Immunizations were performed with RSAV expressing LcrV or Psn. Challenge with a virulent Y. pestis strain was performed 4 weeks after the last immunization. Our results show that the truncated LcrV protein delivered by RASV is sufficient to afford a full protective immune response in a mouse model of bubonic plague and the Psn protein afforded partial protection in a non-optimized system. This finding should facilitate the design and development of a new generation of vaccines against Y. pestis.
KeywordsChallenge Dose Yersinia Pestis Empty Plasmid Oral Immunization Oral Vaccination
Unable to display preview. Download preview PDF.
- Kang, H.Y. and Curtiss, R. (2003) Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol. Med. Microbiol. 37, 99-104.Google Scholar
- Morton, M., Garmory, H.S., Perkins, S.D., O’Dowd, A.M., Griffin, K.F., Turner, A.K., Bennett, A.M. and Titball, R.W. (2004) A Salmonella enterica serovar Typhi vaccine ex-pressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice. Vaccine 22, 2524-2532.CrossRefPubMedGoogle Scholar
- Nakayama, K., Kelly, S.M. and Curtiss, R. (1988) Construction of an asd+expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmo-nella vaccine strain. Biotechnology 6, 693-697.Google Scholar
- Sing, A., Rost, D., Tvardovskaia, N., Roggenkamp, A., Wiedemann, A., Kirschning, C.J., Aepfelbacher, M. and Heesemann, J. (2002) Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196, 1017-1024.CrossRefPubMedPubMedCentralGoogle Scholar
- Titball, R.W., Howells, A.M., Oyston, P.C. and Williamson, E.D. (1997) Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmo-nella typhimurium induces high levels of protection against plague. Infect. Immun. 65, 1926-1930.PubMedPubMedCentralGoogle Scholar